Key Financial Data Of Reporting Company

D.Western Therapeutics Institute, Inc. - Filing #7594917

Concept 2022-01-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-06-30
2021-01-01 to
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
210,034,000 JPY
414,424,000 JPY
201,594,000 JPY
Ordinary profit (loss)
-118,120,000 JPY
-159,711,000 JPY
-82,178,000 JPY
Net assets
1,928,878,000 JPY
2,035,138,000 JPY
2,113,469,000 JPY
Total assets
2,287,217,000 JPY
2,462,860,000 JPY
2,604,424,000 JPY
Basic earnings (loss) per share
-3.76
-3.01
-5.08
-2.83
-1.42
Diluted earnings per share
Equity-to-asset ratio
0.835 xbrli:pure
0.814 xbrli:pure
0.810 xbrli:pure
Net cash provided by (used in) operating activities
-130,420,000 JPY
-176,036,000 JPY
-74,681,000 JPY
Net cash provided by (used in) investing activities
-4,077,000 JPY
-111,150,000 JPY
-100,007,000 JPY
Net cash provided by (used in) financing activities
-76,391,000 JPY
-104,459,000 JPY
-43,379,000 JPY
Cash and cash equivalents
1,749,315,000 JPY
1,933,743,000 JPY
2,100,319,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.